Truist Financial Corp Cytokinetics Inc Transaction History

Truist Financial Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 22, 2022	SELL	$29.74 - $46.0 $389,385 - $602,278	-13,093 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$34.35 - $46.38 $1,408 - $1,901	-41 Reduced 0.31%	13,093 $597,000
Q3 2021 Nov 05, 2021	SELL	$18.54 - $35.74 $352 - $679	-19 Reduced 0.14%	13,134 $470,000
Q2 2021 Aug 16, 2021	SELL	$19.79 - $26.99 $296 - $404	-15 Reduced 0.11%	13,153 $260,000
Q1 2021 May 17, 2021	BUY	$18.57 - $25.68 $15,375 - $21,263	828 Added 6.71%	13,168 $306,000
Q4 2020 Nov 19, 2021	SELL	$15.26 - $28.61 $74,789 - $140,217	-4,901 Reduced 28.43%	12,340 $256,000
Q4 2020 Feb 18, 2021	BUY	$15.26 - $28.61 $77,108 - $144,566	5,053 Added 41.46%	17,241 $358,000
Q3 2020 Nov 13, 2020	BUY	$20.58 - $28.96 $60,525 - $85,171	2,941 Added 31.8%	12,188 $264,000
Q2 2020 Aug 14, 2020	BUY	$11.15 - $24.64 $103,104 - $227,846	9,247 New	9,247 $218,000

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.92B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.